Skip to main content

Articles

6939 result(s) for 'sepsis' within Critical Care

Page 34 of 139

  1. Tumor necrosis factor-alpha (TNF-α), an early mediator in the systemic inflammatory response to infection, is a potential therapeutic target in sepsis. The primary objective of this study was ... -α Fab preparati...

    Authors: Peter E Morris, Brian Zeno, Andrew C Bernard, Xiangning Huang, Shampa Das, Timi Edeki, Steven G Simonson and Gordon R Bernard
    Citation: Critical Care 2012 16:R31
  2. This prospective study investigated the predictive value of procalcitonin (PCT) for survival in 242 adult patients with severe sepsis and septic shock treated in intensive care.

    Authors: Sari Karlsson, Milja Heikkinen, Ville Pettilä, Seija Alila, Sari Väisänen, Kari Pulkki, Elina Kolho and Esko Ruokonen
    Citation: Critical Care 2010 14:R205
  3. Major trauma is characterized by an overwhelming pro-inflammatory response and an accompanying anti-inflammatory response that lead to a state of immunosuppression, as observed after septic shock. Diminished mono...

    Authors: Aurélie Cheron, Bernard Floccard, Bernard Allaouchiche, Caroline Guignant, Françoise Poitevin, Christophe Malcus, Jullien Crozon, Alexandre Faure, Christian Guillaume, Guillaume Marcotte, Alexandre Vulliez, Olivier Monneuse and Guillaume Monneret
    Citation: Critical Care 2010 14:R208
  4. Sepsis is a leading cause of morbidity and ... is characterized by vascular leak. Treatment for sepsis, specifically intravenous fluids, may worsen deterioration ... We therefore sought to quantify vascular leak ...

    Authors: Jay Chandra, Miguel A. Armengol de la Hoz, Gwendolyn Lee, Alexandria Lee, Patrick Thoral, Paul Elbers, Hyung-Chul Lee, John S. Munger, Leo Anthony Celi and David A. Kaufman
    Citation: Critical Care 2022 26:103
  5. This review describes current knowledge on the mechanisms that underlie glucocorticoid insufficiency in sepsis and the molecular action of glucocorticoids. In patients with severe sepsis, numerous factors predisp...

    Authors: Hélène Prigent Sr., Virginie Maxime and Djillali Annane
    Citation: Critical Care 2004 8:243
  6. The benefits and use of low-dose corticosteroids (LDCs) in severe sepsis and septic shock remain controversial. Surviving sepsis campaign guidelines suggest LDC use for septic ... PROGRESS (PROmoting Global Resea...

    Authors: Richard Beale, Jonathan M Janes, Frank M Brunkhorst, Geoffrey Dobb, Mitchell M Levy, Greg S Martin, Graham Ramsay, Eliezer Silva, Charles L Sprung, Benoit Vallet, Jean-Louis Vincent, Timothy M Costigan, Amy G Leishman, Mark D Williams and Konrad Reinhart
    Citation: Critical Care 2010 14:R102
  7. We report data from adult and pediatric patients with severe sepsis from studies evaluating drotrecogin alfa (activated) ... relatively small proportion of patients presenting with severe sepsis; pooling data acr...

    Authors: Jean-Louis Vincent, Simon Nadel, Demetrios J Kutsogiannis, RT Noel Gibney, S Betty Yan, Virginia L Wyss, Joan E Bailey, Carol L Mitchell, Samiha Sarwat, Stephen M Shinall and Jonathan M Janes
    Citation: Critical Care 2005 9:R331
  8. Endothelial activation leading to vascular barrier breakdown denotes a devastating event in sepsis. Angiopoietin (Ang)-2, a circulating ... early time course of Ang-2 release during sepsis in critically ill patie...

    Authors: Philipp Kümpers, Matijs van Meurs, Sascha David, Grietje Molema, Johan Bijzet, Alexander Lukasz, Frank Biertz, Hermann Haller and Jan G Zijlstra
    Citation: Critical Care 2009 13:R64
  9. Sepsis is the most common cause of admission to intensive care units worldwide. Sepsis patients frequently suffer from sepsis-associated encephalopathy (SAE) reflecting acute brain ... biomarkers indicating neuro...

    Authors: Barbora Bircak-Kuchtova, Ha-Yeun Chung, Jonathan Wickel, Johannes Ehler and Christian Geis
    Citation: Critical Care 2023 27:214
  10. The design of clinical trials of interventions aimed at reducing mortality in patients with severe sepsis assumes that the relative treatment effect of ... data from phase III clinical studies of severe sepsis to...

    Authors: William L Macias, David R Nelson, Mark Williams, Rekha Garg, Jonathan Janes and Andreas Sashegyi
    Citation: Critical Care 2005 9:R607
  11. Mild hypoglycemia is associated with increased mortality in critically ill patients. However, data regarding the association between mild hypoglycemia and patient outcomes among patients with sepsis are limited.

    Authors: Sunghoon Park, Dong-Gyu Kim, Gee Young Suh, Jun Goo Kang, Young-Su Ju, Yong-Jae Lee, Ji Young Park, Seok Won Lee and Ki-Suck Jung
    Citation: Critical Care 2012 16:R189
  12. Microvascular dysregulation characterized by hyporesponsive vessels and heterogeneous bloodflow is implicated in the pathogenesis of organ failure in sepsis. The renin-angiotensin system (RAS) affects ... relatio...

    Authors: Kevin C Doerschug, Angela S Delsing, Gregory A Schmidt and Alix Ashare
    Citation: Critical Care 2010 14:R24
  13. Acute kidney injury (AKI) often complicates sepsis and is associated with high morbidity and ... important clinical trials have improved our understanding of sepsis-associated AKI (SA-AKI) and impacted clinical c...

    Authors: Matthieu Legrand, Sean M. Bagshaw, Pavan K. Bhatraju, Azra Bihorac, Ellen Caniglia, Ashish K. Khanna, John A. Kellum, Jay Koyner, Michael O. Harhay, Fernando G. Zampieri, Alexander Zarbock, Kevin Chung, Kathleen Liu, Ravindra Mehta, Peter Pickkers, Abigail Ryan…
    Citation: Critical Care 2024 28:92
  14. During septic shock, resistance to the haemodynamic effects of catecholamine vasopressors and inotropes is a well-recognised marker of mortality risk. However, the specific cardiovascular or metabolic response el...

    Authors: Anand Kumar, Elizabeth Schupp, Eugene Bunnell, Amjad Ali, Barry Milcarek and Joseph E Parrillo
    Citation: Critical Care 2008 12:R35
  15. To determine if neighborhood socioeconomic deprivation independently predicts 30-day mortality and readmission for patients with sepsis or critical illness after adjusting for individual...

    Authors: Jay B. Lusk, Beau Blass, Hannah Mahoney, Molly N. Hoffman, Amy G. Clark, Jonathan Bae, Deepshikha C. Ashana, Christopher E. Cox and Bradley G. Hammill
    Citation: Critical Care 2023 27:287
  16. Drotrecogin alfa (activated; recombinant activated protein C) was shown to reduce 28-day all-cause mortality in patients with severe sepsis and to have an acceptable safety profile ... (activated) in 2786 adult p...

    Authors: Gordon R Bernard, William L Macias, David E Joyce, Mark D Williams, Joan Bailey and Jean-Louis Vincent
    Citation: Critical Care 2003 7:155
  17. Sepsis is the leading cause of death in ... limitations of earlier mathematical models used to describe sepsis and predict outcomes, we designed an empirically ... Monte Carlo model that simulates the progression...

    Authors: Görkem Saka, Jennifer E Kreke, Andrew J Schaefer, Chung-Chou H Chang, Mark S Roberts and Derek C Angus
    Citation: Critical Care 2007 11:R65
  18. We designed a prospective observational study to investigate the independent association of fever and the use of antipyretic treatments with mortality in critically ill patients with and without sepsis. We includ...

    Authors: Byung Ho Lee, Daisuke Inui, Gee Young Suh, Jae Yeol Kim, Jae Young Kwon, Jisook Park, Keiichi Tada, Keiji Tanaka, Kenichi Ietsugu, Kenji Uehara, Kentaro Dote, Kimitaka Tajimi, Kiyoshi Morita, Koichi Matsuo, Koji Hoshino, Koji Hosokawa…
    Citation: Critical Care 2012 16:R33

    The Erratum to this article has been published in Critical Care 2012 16:450

  19. Early fluid management in patients with advanced chronic kidney disease (CKD) and sepsis-induced hypotension is challenging with limited evidence ... an early restrictive versus liberal fluid management for sepsis

    Authors: Anselm Jorda, Ivor S. Douglas, Thomas Staudinger, Gottfried Heinz, Felix Bergmann, Rainer Oberbauer, Gürkan Sengölge, Markus Zeitlinger, Bernd Jilma, Nathan I. Shapiro and Georg Gelbenegger
    Citation: Critical Care 2024 28:231
  20. Genetic variations may influence clinical outcomes in patients with sepsis. The present study was conducted to evaluate...

    Authors: Jose Garnacho-Montero, Teresa Aldabo-Pallas, Carmen Garnacho-Montero, Aurelio Cayuela, Rocio Jiménez, Sonia Barroso and Carlos Ortiz-Leyba
    Citation: Critical Care 2006 10:R111
  21. A major pathophysiologic mechanism in sepsis is impaired host immunity which results in...

    Authors: Katherine Chang, Catherine Svabek, Cristina Vazquez-Guillamet, Bryan Sato, David Rasche, Strother Wilson, Paul Robbins, Nancy Ulbrandt, JoAnn Suzich, Jonathan Green, Andriani C Patera, Wade Blair, Subramaniam Krishnan and Richard Hotchkiss
    Citation: Critical Care 2014 18:R3
  22. Despite significant progress in our understanding of the pathophysiology of sepsis and extensive clinical research, there are few ... the literature evaluating immunotherapy in adult patients with sepsis, emphasi...

    Authors: Marleen A. Slim, Niels van Mourik, Lieke Bakkerus, Katherine Fuller, Lydia Acharya, Tatiana Giannidis, Joanna C. Dionne, Simon J. W. Oczkowski, Mihai G. Netea, Peter Pickkers, Evangelos J. Giamarellos-Bourboulis, Marcella C. A. Müller, Tom van der Poll, W. Joost Wiersinga, Alexander P. J. Vlaar and Lonneke A. van Vught
    Citation: Critical Care 2024 28:183
  23. Recent evidence suggests a link between excess lipid peroxidation and specific organ failures in sepsis. No study has been performed in sepsis by multidrug-resistant (MDR) Gram-negative...

    Authors: Chryssoula Toufekoula, Vassileios Papadakis, Thomas Tsaganos, Christina Routsi, Stylianos E Orfanos, Anastasia Kotanidou, Dionyssia-Pinelopi Carrer, Maria Raftogiannis, Fotini Baziaka and Evangelos J Giamarellos-Bourboulis
    Citation: Critical Care 2013 17:R6
  24. Altered pharmacokinetics (PK) in critically ill patients can result in insufficient serum β-lactam concentrations when standard dosages are administered. Previous studies on β-lactam PK have generally excluded th...

    Authors: Fabio Silvio Taccone, Pierre-François Laterre, Thierry Dugernier, Herbert Spapen, Isabelle Delattre, Xavier Wittebole, Daniel De Backer, Brice Layeux, Pierre Wallemacq, Jean-Louis Vincent and Frédérique Jacobs
    Citation: Critical Care 2010 14:R126
  25. The causative role of new hydroxyethyl starch (HES 130/0.4) in renal dysfunction frequency (a > 50% increase in serum creatinine or need for renal replacement therapy (RRT)) remains debated. Using the database of...

    Authors: Laurent Muller, Samir Jaber, Nicolas Molinari, Laurent Favier, Jérôme Larché, Gilles Motte, Sonia Lazarovici, Luc Jacques, Sandrine Alonso, Marc Leone, Jean Michel Constantin, Bernard Allaouchiche, Carey Suehs and Jean-Yves Lefrant
    Citation: Critical Care 2012 16:R34
  26. Mitochondrial dysfunction has been suggested as a contributing factor to the pathogenesis of sepsis-induced multiple organ failure. Also, restoration ... the recovery of organ function in patients with sepsis. He...

    Authors: Fredrik Sjövall, Saori Morota, Magnus J Hansson, Hans Friberg, Erich Gnaiger and Eskil Elmér
    Citation: Critical Care 2010 14:R214
  27. Prior to investing in a large, multicentre randomised controlled trial (RCT), the National Institute for Health Research in the UK called for an evaluation of the feasibility and value for money of undertaking a ...

    Authors: Marta O Soares, Nicky J Welton, David A Harrison, Piia Peura, Manu Shankar-Hari, Sheila E Harvey, Jason Madan, Anthony E Ades, Kathryn M Rowan and Stephen J Palmer
    Citation: Critical Care 2014 18:649
  28. The global burden of sepsis is concentrated in sub-Saharan Africa, where ... unique. In this context, poor understanding of sepsis immunopathology represents a crucial barrier to development ... inter-individual ...

    Authors: Matthew J. Cummings, Barnabas Bakamutumaho, Adam Price, Nicholas Owor, John Kayiwa, Joyce Namulondo, Timothy Byaruhanga, Moses Muwanga, Christopher Nsereko, Stephen Sameroff, Rafal Tokarz, Wai Wong, Shivang S. Shah, Michelle H. Larsen, W. Ian Lipkin, Julius J. Lutwama…
    Citation: Critical Care 2022 26:36
  29. The benefits of extracorporeal membrane oxygenation (ECMO) in children with sepsis remain controversial. Current guidelines on management of ... publications on effectiveness of ECMO in children with sepsis.

    Authors: Kollengode Ramanathan, Nicholas Yeo, Peta Alexander, Lakshmi Raman, Ryan Barbaro, Chuen Seng Tan, Luregn J. Schlapbach and Graeme MacLaren
    Citation: Critical Care 2020 24:684
  30. It is not well understood whether the process of autophagy is accelerated or blocked in sepsis, and whether it is beneficial or harmful ... immune defense mechanism over a time course during sepsis. Our aim was t...

    Authors: Waka Takahashi, Eizo Watanabe, Lisa Fujimura, Haruko Watanabe-Takano, Hiroyuki Yoshidome, Paul E Swanson, Takeshi Tokuhisa, Shigeto Oda and Masahiko Hatano
    Citation: Critical Care 2013 17:R160
  31. Severe sepsis is associated with a high mortality rate ... the crucial role of immunologic derangement in severe sepsis, thymosin alpha 1 (Tα1) is considered ... mortality rates and immunofunction in patients wit...

    Authors: Jianfeng Wu, Lixin Zhou, Jiyun Liu, Gang Ma, Qiuye Kou, Zhijie He, Juan Chen, Bin Ou-Yang, Minying Chen, Yinan Li, Xiaoqin Wu, Baochun Gu, Lei Chen, Zijun Zou, Xinhua Qiang, Yuanyuan Chen…
    Citation: Critical Care 2013 17:R8
  32. A potential independent association was recently demonstrated between high red blood cell distribution width (RDW) and the risk of all-cause mortality in critically ill patients, although the mechanism underlying...

    Authors: Chan Ho Kim, Jung Tak Park, Eun Jin Kim, Jae Hyun Han, Ji Suk Han, Jun Yong Choi, Seung Hyeok Han, Tae-Hyun Yoo, Young Sam Kim, Shin Wook Kang and Hyung Jung Oh
    Citation: Critical Care 2013 17:R282
  33. Sepsis is associated with significant mortality. Yet,...PCSK9...loss-of-function (LOF) and inhibition, through enhanced low-density lipoprotein receptor (LDLR) mediated endotoxin clearance, holds promise as a pot...

    Authors: Mihir R. Atreya, Natalie Z. Cvijanovich, Julie C. Fitzgerald, Scott L. Weiss, Michael T. Bigham, Parag N. Jain, Adam J. Schwarz, Riad Lutfi, Jeffrey Nowak, Geoffrey L. Allen, Neal J. Thomas, Jocelyn R. Grunwell, Torrey Baines, Michael Quasney, Bereketeab Haileselassie, Matthew N. Alder…
    Citation: Critical Care 2023 27:250
  34. Plasma selenium (Se) concentrations are reduced in critically ill surgical patients, and lower plasma Se concentrations are associated with worse outcomes. We investigated whether adjuvant Se supplementation in t...

    Authors: Yasser Sakr, Vivian PL Maia, Clesar Santos, Julia Stracke, Mohamed Zeidan, Ole Bayer and Konrad Reinhart
    Citation: Critical Care 2014 18:R68
  35. Systemic inflammation in sepsis is initiated by interactions between pathogen molecular...

    Authors: Joëlle Rolli, Noureddine Loukili, Sandra Levrand, Nathalie Rosenblatt-Velin, Stéphanie Rignault-Clerc, Bernard Waeber, François Feihl, Pal Pacher and Lucas Liaudet
    Citation: Critical Care 2010 14:R160
  36. Despite recent modifications, the clinical definition of the acute respiratory distress syndrome (ARDS) remains non-specific, leading to under-diagnosis and under-treatment. This study was designed to test the hy...

    Authors: Lorraine B Ware, Tatsuki Koyama, Zhiguo Zhao, David R Janz, Nancy Wickersham, Gordon R Bernard, Addison K May, Carolyn S Calfee and Michael A Matthay
    Citation: Critical Care 2013 17:R253
  37. Serial alterations in protein C levels appear to correlate with disease severity in patients with severe sepsis, and it may be possible to tailor severe sepsis therapy with the use of this biomarker. ... compared...

    Authors: Andrew F Shorr, Jonathan M Janes, Antonio Artigas, Jyrki Tenhunen, Duncan LA Wyncoll, Emmanuelle Mercier, Bruno Francois, Jean-Louis Vincent, Burkhard Vangerow, Darell Heiselman, Amy G Leishman, Yajun E Zhu and Konrad Reinhart
    Citation: Critical Care 2010 14:R229
  38. Prevention of lymphocyte apoptosis by caspase inhibition has been proposed as a novel treatment approach in sepsis. However, it has not been clearly demonstrated that caspase inhibitors improve survival in sepsis

    Authors: Peter Weber, Ping Wang, Stephane Maddens, Paul SH Wang, Rongqian Wu, Michael Miksa, Weifeng Dong, Michael Mortimore, Julian MC Golec and Peter Charlton
    Citation: Critical Care 2009 13:R146
  39. Immunomodulatory therapies that improve the outcome of sepsis are not available. We sought to determine whether treatment of critically ill patients with sepsis with low-dose erythromycin—a macrolide antibiotic.....

    Authors: Tom D. Y. Reijnders, Hessel Peters-Sengers, Lonneke A. van Vught, Fabrice Uhel, Marc J. M. Bonten, Olaf L. Cremer, Marcus J. Schultz, Martijn M. Stuiver and Tom van der Poll
    Citation: Critical Care 2022 26:151

    The Correspondence to this article has been published in Critical Care 2023 27:70

    The Correspondence to this article has been published in Critical Care 2023 27:52